ABSORPTION OF THYROTROPIN-RELEASING HORMONE AFTER ORAL ADMINISTRATION OF TRH TARTRATE MONOHYDRATE IN THE RAT, DOG AND HUMAN
スポンサーリンク
概要
- 論文の詳細を見る
Quantitative blood levels of thyrotropin-releasinghormone (TRH) were determined a sensitive and specific radioimmunoassay after oral administration or intravenous injection of thyrotropin-releasing hormone tartrate monohydrate (TRH-T) in the rat, dog and human. A pharmacokinetic analysis after intravenous injection of the drug revealed biphasic elimination of the whole blood concentration following a two-compartment open model with a half-life in α-phase of 2.6 min and β-phase of 4.6 min in the rat (dose : 500 μg/kg); a half-life in α-phase of 3.2 min and β-phase of 18.1 min in the beagle-dog (dose : 146 μg/dog); a half-life in α-phase of 4.0 min and β-phase of 20.4 min in the human (dose : 730 μg/human). The absolute bioavailability of TRH after oral administration of TRH-T solution in 24h fasting rats were 1.5,0.4 and 0.2% at 29.2,146,and 730 mg/kg dosing levels, respectively (e.q. 20,100,500 mg/kg of TRH) compared with i.v. injection (dose : 500 μg/kg). In beagledogs, they were 12.6,9.8,5.6,and 2.92,14.6,29.2,and 146 mg/dog dosing levels, respectively (e.q. 2,10,20,and 100 mg/dog of TRH) compared with i.v. injection (dose : 146 μg/dog). Those of after meal in beagle-dogs were 6.0 and 2.3% at 2.92 and 29.2 mg/dog dosing levels (e.q. 2,and 20 mg/dog of TRH). Thus, TRH absorption showed apparent saturation and was decreased by food ingestion. The absolute bioavailability in the humans, who were administered 11.7 mg TRH-T (2.92 mg/tablet×four, e.q. 8 mg of TRH) two hours after meal, was 2.0% on the average, and thyroid stimulating hormone levels were significantly increased by oral administration of TRH-T tablets.
- 公益社団法人日本薬学会の論文
著者
-
Yamashita Kenji
Central Research Division Takeda Chemical Industries Ltd.
-
TAKEUCHI Juji
Department of Neurosurgery, National Utano Hospital, Kyoto
-
Kitamori Nobuyuki
Central Research Division Takeda Chemical Industries Ltd.
-
Takeuchi Juji
Department Of Neurosurgery Kyoto University Medical School
-
Takeuchi Juji
Department Of Neurosurgery Kyoto University Medical School: (present Address) Fukui Red Cross Hospit
-
Toguchi Hajime
Central Research Division Takeda Chemical Industries Ltd.
-
YOKOHAMA SHIGEHARU
Central Research Division, Takeda Chemical Industries, Ltd.
-
Yokohama Shigeharu
Central Research Division Takeda Chemical Industries Ltd.
-
KITAMORI NOBUYUKI
Central Research Division, Takeda Chemical Industries, Ltd.
関連論文
- Pineal Dermoid Cyst Developing 18 years after Gross Total Removal of a Pineal Mature Teratoma : Case Report
- ABSORPTION OF THYROTROPIN-RELEASING HORMONE AFTER ORAL ADMINISTRATION OF TRH TARTRATE MONOHYDRATE IN THE RAT, DOG AND HUMAN
- RADIOIMMUNOASSAY OF THYROTROPIN-RELEASING HORMONE (TRH) IN RAT, DOG, AND HUMAN BLOOD
- Induction of Killer Activity Following Local Irradiation in Intracranial Tumor-Bearing Mice
- INTESTINAL ABSORPTION MECHANISMS OF THYROTROPINRELEASING HORMONE
- INTESTINAL ABSORPTION MECHANISMS OF γ-BUTYROLACTONE-γ-CARBONYL-L-HISTIDYL-L-PROLINAMIDE CITRATE (DN-1417) AND THYROTROPIN-RELEASING HORMONE (TRH)
- ABSORPTION OF γ-BUTYROLACTONE-γ-CARBONYL-L-HISTIDYL-L-PROLINAMIDE CITRATE (DN-1417), AN ANALOG OF THY-ROTROPIN-RELEASING HORMONE, IN RATS AND DOGS
- B-13. Effecu of 1-(2-Chloroethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) on Brain Tumors
- B-4. Tumor Specific Antigen of Brain Tumor
- BLOOD LEVEL AND BRAIN DISTRIBUTION OF THYROTROPIN-RELEASING HORMONE (TRH) DETERMINED BY RADIOIMMUNOASSAY AFTER INTRAVENOUS ADMINISTRATION IN RATS